Interim results of INJECT study show real-world Jetrea experience

DENVER — The long-term effects of Jetrea may be as safe and effective as those seen in registration trials, according to a presentation here.In a poster presented at the Association for Research in Vision and Ophthalmology annual meeting, Peter Stalmans, MD, PhD, and colleagues discussed the non-interventional, multicenter, prospective INJECT study of 105 patients with vitreomacular traction (VMT) treated with Jetrea (ocriplasmin, ThromboGenics).